Core Laboratories Expects Q1 2026 Revenue And Earnings To Be Below Its Previously Issued Guidance Provided On February 4, 2026; Expects Q1 EPS To Be Between $0.05-$0.07; Revises Guidance For Q1 2026 Revenue Ranges From $119M To $123M

Core Laboratories Inc. (NYSE: CLB) has revised its guidance for Q1 2026, expecting revenue to range between $119 million and $123 million, and earnings per share (EPS) to be between $0.05 and $0.07. This adjustment is due to regional instability in the Middle East affecting client activity, project delays, and supply-chain disruptions. The company is prioritizing employee safety while managing operations amid these challenges, particularly impacting its Reservoir Description segment.